IP Library Granted Patent US 8,653,041
Granted Patent B2
US 8,653,041 · App. 13/652,163 · Granted Feb 18, 2014

Antibacterial aminoglycoside analogs

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,653,041
App. No.
13/652,163
Granted
Feb 18, 2014
Kind
B2
Abstract

Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein Q 1 and Q 2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

Claims (30)

1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier, diluent or excipient and a compound having the following structure (I):

or a stereoisomer or pharmaceutically acceptable salt thereof,

wherein:

Q 1 is —NHR 1 ;

Q2 is

R 1 is C 2 -C 6 alkyl substituted with one or two hydroxyl groups;

R 2 is hydrogen or C 1 -C 6 alkyl optionally substituted with one or more halogen, hydroxyl or amino; and

n is an integer from 1 to 4.

2. A pharmaceutical composition according to claim 1 , wherein R 1 is C 2 -C 6 alkyl substituted with one hydroxyl group.

3. A pharmaceutical composition according to claim 2 , wherein R 1 is —(CH 2 ) m OH, wherein m is an integer from 2 to 6.

4. A pharmaceutical composition according to claim 3 , wherein R 1 is —(CH 2 ) 2 OH or —(CH 2 ) 3 OH.

5. A pharmaceutical composition according to claim 4 , wherein R 1 is —(CH 2 ) 2 OH.

6. A pharmaceutical composition according to claim 2 , wherein R 1 is —(CH 2 ) p CH(CH 3 )OH, wherein p is an integer from 1 to 4.

7. A pharmaceutical composition according to claim 6 , wherein R 1 is —CH 2 CH(CH 3 )OH or —(CH 2 ) 2 CH(CH 3 )OH.

8. A pharmaceutical composition according to claim 1 , wherein R 1 is C 2 -C 6 alkyl substituted with two hydroxyl groups.

9. A pharmaceutical composition according to claim 8 , wherein R 1 is —CH 2 CH(OH)(CH 2 ) q OH wherein q is an integer from 1 to 4.

10. A pharmaceutical composition according to claim 9 , wherein R 1 is —CH 2 CH(OH)CH 2 OH or —CH 2 CH(OH)(CH 2 ) 2 OH.

11. A pharmaceutical composition according to claim 8 , wherein R 1 is —(CH 2 ) r CH(CH 2 OH) 2 wherein r is 0 or an integer from 1 to 3.

12. A pharmaceutical composition according to claim 11 , wherein R 1 is —CH 2 CH(CH 2 OH) 2 or —CH(CH 2 OH) 2 .

13. A pharmaceutical composition according to claim 12 , wherein R 2 is hydrogen.

14. A pharmaceutical composition according to claim 13 , wherein Q 2 is:

15. A pharmaceutical composition according to claim 14 , wherein Q 2 is:

16. A pharmaceutical composition according to claim 14 , wherein Q 2 is:

17. A pharmaceutical composition according to claim 1 , wherein said compound has the configuration:

18. A pharmaceutical composition according to claim 1 , wherein said compound is:

or a pharmaceutically acceptable salt thereof.

19. A pharmaceutical composition according to claim 18 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

20. A pharmaceutical composition according to claim 18 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

Assignments (2)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 19, 2019
From: ACHAOGEN, INC.
To: SILICON VALLEY BANK
Reel/Frame 048947/0702 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2013
From: GOLDBLUM, ADAM AARON; DOZZO, PAOLA; KANE, TIMOTHY ROBERT; AGGEN, JAMES BRADLEY; LINSELL, MARTIN SHERINGHAM; HILDEBRANDT, DARIN JAMES; GLIEDT, MICAH JAMES
To: ACHAOGEN, INC.
Reel/Frame 030044/0384 →